ANDROFORTE 5 Price

Overview

Welcome to Dwaey, specifically on ANDROFORTE 5 Cream page.
This medicine contains an important and useful components, as it consists of Testosterone.
ANDROFORTE 5 is available in the market in concentration 50mg/ml and in the form of Cream.

Lawley Pharmaceuticals Pty Ltd is the producer of ANDROFORTE 5 and it is imported from AUSTRALIA, The most popular alternatives of ANDROFORTE 5 are listed downward .

Mode Of Action

Testosterone is the principal endogenous androgen responsible for promoting the growth and development of male sexual organs and maintaining secondary sex characteristics in androgen-deficient males.

Indication

• Hypogonadism
• Testosterone replacement therapy

Precaution

Cardiovascular disorders, skeletal metastases, renal or hepatic impairment, epilepsy, migraine, diabetes or other conditions which may be aggravated by fluid retention, eg heart failure. Elderly, prepubertal boys. Monitor signs of virilization (females) and development of priapism or excessive sexual stimulation (males). Periodic haemoglobin, lipid determinations and rectal prostate examination. Lactation: Drug is excreted into breast milk; use is contraindicated

Side Effects

• >10% Pruritus at application site (37%)
• Skin reactions at application site (16.1%)
• Blisters under skin (12%) 1-10% Erythema at application site (7%)
• Vesicles at application site (6%)
• Allergic contact dermatitis (4%)
• Burning at application site (3%)
• Induration at application site (3%) Frequency Not Defined Abnormal dreams
• Acne
• Anaphylaxis
• Bladder irritability
• Breast soreness
• Cholestatic jaundice
• Deep vein thrombosis
• Dry skin
• Fatigue
• Gynecomastia
• Headache
• Insomnia
• Menstrual irregularities
• Priapism
• Suppression of factors II
• V
• VII
• Virilization

Contra indication

Hypercalcaemia or hypercalciuria, males with breast or prostate carcinoma. Pregnancy and lactation.

Pregnancy and lactation

Pregnancy category: X

Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.